| ACEI | Angiotensin-Converting Enzyme Inhibitor |
| ACTH | Adrenocorticotropic Hormone |
| ADH | Antidiuretic Hormone |
| ANP | Atrial Natriuretic Peptide |
| AQP2 | Aquaporin 2 |
| ARB | Angiotensin II Receptor Blocker |
| ARNI | Angiotensin Receptor Neprilysin Inhibitor |
| AT1 | Angiotensin II Receptor Type 1 |
| BB | Beta-receptor Blockers |
| CBP | Cleansing Bowel Preparations |
| CBZ | Carbamazepine |
| CCB | Calcium-channel Blocker |
| CTLA-4 | Cytotoxic T Lymphocyte Associated Protein-4 |
| CYC | Cyclophosphamide |
| CYP2D6 | Cytochrome P450 2D6 |
| EGFR | Epidermal Growth Factor Receptor |
| ENaC | Epithelial Sodium Channel |
| GABA | γ-Aminobutyric Acid |
| GFR | Glomerular Filtration Rate |
| IGF-1R | Type 1 Human Insulin-like Growth Factor Receptor |
| MDMA | 3,4-Methylenedioxymethamphetamine (ecstasy) |
| MPH | Methylphenidate |
| NCC | NaCl Co-transporter |
| NKCC2 | Na-K-2Cl Co-transporter 2 |
| NSAID | Non-steroidal Anti-inflammatory Drug |
| NSIAD | Nephrogenic Syndrome of Inappropriate Antidiuresis |
| OXC | Oxcarbazepine |
| PD-1 | Programmed Cell Death Protein 1 |
| PD-L1 | Programmed Death Ligand 1 |
| PGE2 | Prostaglandin E2 |
| PGT | Prostaglandin Transporter |
| PPI | Proton Pump Inhibitor |
| RAAS | Renin–Angiotensin–Aldosterone System |
| SAI | Secondary Adrenal Insufficiency |
| SGLT-2 | Sodium-glucose Co-transporter-2 |
| SIAD | Syndrome of Inappropriate Antidiuresis |
| SIADH | Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| SNRI | Serotonin and Norepinephrine Reuptake Inhibitor |
| SSRI | Selective Serotonin Reuptake Inhibitor |
| TCA | Tricyclic Antidepressant |
| TMP–SMX | Trimethoprim–Sulfamethoxazole (cotrimoxazole) |
| VEGF | Vascular Endothelial Growth Factor |